A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration
Conclusions
A genomic and clinical prognostic index readily available for clinical use was successfully validated, warranting further clinical evaluation for prognostic prediction and clinical trial stratification and enrichment for preventive interventions.
Source: Gut - Category: Gastroenterology Authors: King, L. Y., Canasto-Chibuque, C., Johnson, K. B., Yip, S., Chen, X., Kojima, K., Deshmukh, M., Venkatesh, A., Tan, P. S., Sun, X., Villanueva, A., Sangiovanni, A., Nair, V., Mahajan, M., Kobayashi, M., Kumada, H., Iavarone, M., Colombo, M., Fiel, M. I., Tags: Hepatic cancer Hepatology Source Type: research
More News: Bilirubin | Cancer | Cancer & Oncology | Carcinoma | Children | Cirrhosis | Clinical Trials | Gastroenterology | Genetics | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver | Liver Cancer | Study | Training | Universities & Medical Training | Urology & Nephrology